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ABSTRACT
Introduction: Dengue is the most important mosquito-borne flavivirus disease. The number of
Dengue cases in Indonesia in 2010 range from 150,000 cases with the deaths of around 1,317
people. Huge number of cases have made Indonesia was the first ranked as the state with the
highest Dengue cases in the ASEAN region and the world’s second ranking after Brazil. The drugs or
antibiotics that can be administered effectively to cure this disease has not been found yet. Many
study have been done and some that have been reported include viral RNA synthesis inhibitors,
protein inhibitors of NS3 helicase and protease and inhibitors that inhibit Dengue virus maturation.
Curcumin have preventive activity against several viruses: vasicular stomatis ( VSV ), HSV 1 and 2,
parainfluenza - 3, reovirus - 1, feline corona virus, feline herpes virus . Curcumin also known have
ubiquitin proteasome inhibition system was able to decrease the production of Japanese ensefalitis
virus.
Objectives: This study aims to determine safe concentrations of curcumin against vero cells (cytotoxic
test results) and know the Dengue-2 antiviral potency of curcumin.
Methods: Including quasi-experimental study. The anti viral potency of curcumin seen from the
result of immunocytochemistry Streptavidin Biotin Peroxidase Complex (SBPC). Data were analyzed
by ANOVA.
Results: The results showed that secure concentrations from cytotoxic of curcumin against vero
cells is 6.25 ppm. The calculation of positive rate from immunocytochemistry in vero cells infected
by Dengue - 2 incubation 1 and 3 days were the result is significantly different than the control.
Conclusion: The secure concentration of curcumin against vero cells was 6.25 ppm and curcumin
was able to lower the positive rate due to Dengue-2 infection.
Key Words : Dengue virus, Curcumin, Immunocytochemistry.
INTISARI
Pendahuluan: Dengue adalah penyakit flavivirus paling penting yang ditularkan oleh nyamuk.
Jumlah kasus Demam Berdarah Dengue (DBD) di Indonesia pada tahun 2010 berkisar 150.000
kasus dengan kematian sekitar 1.317 orang. Jumlah kasus yang besar ini membuat Indonesia menjadi
peringkat pertama sebagai negara dengan kasus DBD tertinggi di kawasan ASEAN dan peringkat
kedua di dunia setelah Brazil. Sampai saat ini belum ditemukan obat – obatan ataupun antibiotik
yang efektif yang dapat diberikan untuk menyembuhkan penyakit ini. Berbagai senyawa dilaporkan
mencakup penghambat sintesis RNA virus, inhibitor NS3 protein helikase dan protease serta inhibitor
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yang menghambat pematangan virus Dengue. Kurkumin terbukti memiliki aktivitas preventif terhadap
beberapa virus, antara lain: vasicular stomatis (VSV), HSV 1 dan 2, parainfluenza-3, reovirus-1, feline
corona virus, feline herpes virus. Kurkumin juga diketahui mampu melakukan penghambatan sistem
ubiquitin-proteasome yang menyebabkan penurunan produksi virus Japanese ensefalitis.
Tujuan: Penelitian ini bertujuan untuk mengetahui konsentrasi yang aman dari kurkumin terhadap
sel vero (hasil uji sitotoksik) dan mengetahui potensi antiviral kurkumin terhadap Dengue-2.
Metode: Termasuk penelitian kuasi eksperimental. Potensi anti viral kurkumin dilihat dari hasil uji
imunositokimia Streptavidin Biotin Peroxidase Complex (SBPC). Data dianalisis dengan ANOVA.
Hasil: Hasil uji sitotoksik menunjukkan konsentrasi kurkumin yang aman terhadap sel vero adalah
6,25 ppm. Hasil perhitungan nilai positive rate dari uji imunositokimia pada sel vero yang diinfeksi
Dengue-2 inkubasi 1 hari dan 3 hari dengan perlakuan kurkumin dibandingkan kontrol adalah
berbeda nyata.
Simpulan: Konsentrasi kurkumin yang aman terhadap sel vero adalah 6,25 ppm dan diketahui
kurkumin mampu menurunkan nilai positive rate akibat infeksi Dengue-2.
Kata kunci: Virus Dengue, kurkumin, imunositokimia.
INTRODUCTION
Dengue is the most important mosquito-
borne flavivirus disease. People living in the
tropical and subtropical areas are at risk of
Dengue virus infection. More than Dengue
infected cases occur worldwide each year. The
number of Dengue cases in Indonesia in 2010
range from 150,000 cases with the deaths of
around 1,317 people. Huge number of cases
have made Indonesia was the first ranked as
the state with the highest Dengue cases in the
ASEAN region and the world’s second ranking
after Brazil1.
Dengue infection is caused by Dengue virus
transmitted to humans by the mosquito. These
viruses belongs to the Flaviviridae family of RNA
viruses. Dengue virus has four serotypes of
Dengue-1, Dengue-2, Dengue-3 and Dengue -4.
Clinical syndroms in humans caused by Dengue
virus ranging from an acute self-limited febrile
illness (Dengue fever, DF) to Dengue Haemor-
rhagic Fever (DHF) and Dengue Shock Syndrome
(DSS)2.
The drugs or antibiotics that can be
administered effectively to cure this disease has
not been found yet. Handling Dengue cases was
usually done only to relieve symptoms with
intravenous fluids.3 Many have been studied
extensively and some that have been reported
to act as inhibitors of RNA synthesis, protein
inhibitors of NS3, protease inhibitors that inhibit
Dengue virus maturation and polianion mono-
clonal antibody that prevents binding to host
cell receptors4, 5.
Curcumin is known have the preventive
activity against several viruses, such as vasicular
stomatis (VSV), HSV 1 and 2, parainfluenza-3,
reovirus-1, feline corona virus, feline herpes virus
and other viruses with EC50 0.019 to 0.105 µM
6.
Curcumin also known have ubiquitin protea-
some inhibition system was able to decrease
the production of Japanese ensefalitis virus7.
Curcumin, a hydrophobic polyphenol compound
derived from the rhizome of the herb Curcuma
longa an Indonesian traditional medicinal plants.
Some of this considerations underlying the use
of curcumin was tested in Dengue virus.
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Curcumin has a wide spectrum of biological
and pharmacological activities, such as
anticancer, antimutagenic, anticoagulant,
antifertilitas, antidiabetic, antibacterial, anti-
fungal, antiprotozoa, antiviral and antifibrosis8.
The pharmacological activities of curcumin
associated with as double bonds in the
curcumin’s central chain,-diketone group, and
a hydroxy phenolic group9. This study was
conducted to determine the cytotoxic effects of
curcumin and to test the activity of curcumin
against Dengue-2 in vitro. The Antiviral potency
of curcumin known by Streptavidin Biotin
Peroxidase Complex (SBPC) immunocyto-
MATERIAL AND METHODS
This study was an experimental study. Five
mg of Curcumin (1,7-bis (4’hidroksi - 3 metho-
xyphenyl)-1,6 heptadien, 3,5-dione) was
dissolved in 100 µl dimethyl sulfoxide (DMSO)
as stock solution.
Cytotoxic test were carried out using the
MTT [3 - (4,5-dimetiiazol-2-i1) -2,5 difeniltetra-
zolium bromide]. Cells at a density of 104 vero
cells/wells distributed in wells (well plate) and
incubated for 24 hours. Followed by the addition
of curcumin with 7 (seven) concentration series
of 50, 25, 12.5, 6.25, 3.125, 1.5625 and 0.78125
ppm respectively - each of 4 replications. Solvent
that used to dissolve the test compound was
dimethylsulfoxide (DMSO). The cytotoxicity test
results read by Elisa reader with a wavelength
of 595 nm, the absorbance data obtained
converted into living cells or the percentage of
cell viability that can be calculated with the
following formula.
Figure 1. Structure of [1,7-bis-(4'-hidroksi-3'-
metoksifenil)hepta-1,6-diena-3,5-dion]
(curcumin)10
chemistry. Here is a chemical structure of
curcumin.
Immunocytochemistry SBPC
Vero cell at a density of 5 x 105 cells per well
were grown in a well plate. Each given a deck
plate glass that has been coated with poly elysin
as the attachment of cells . Well plate is divided
into two (2) incubation of the incubation groups
(1) and three (3) days . Each group was divided
into groups of Dengue - 2 virus infected 1 day
incubation and were given curcumin, the positive
control (cells infected by Dengue 2 of incubation
1 days) and cells infected by Dengue - 2
incubation 1 day but not given DSSE10 as primary
antibody of immunocytochemistry staining as
immunocytochemistry control and negative
control (uninfected cells 1 day incubation). The
division of the group on the infected cell for
three (3) days is similar to one (1) day
incubation.
Immunocytochemistry SBPC11
Sample to be tested were fixed with cold
methanol and washed with PBS. The sample
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then inundated in peroxidase blocking solution
at room temperature for 10 minutes, to remove
endogenous peroxidase activity, then washed
with distilled water. Sample incubated in the
background sniper (protein blocking solution)
for 10 minutes at room temperature. Primary
antibodies (DSSE10 monoclonal antibodies 1:10)
was added 100 mL per sample (adjusted until
all parts were flooded) and then incubated in a
moist tray overnight. Sample then washed with
PBS for 2 x 2 minutes. Trekkie universal link
(secondary antibody) was added to 30 mL per
sample and incubated at room temperature (250
C) for 15 minutes and washed with PBS for 2 x 2
minutes. Trekavidin - HRP reagent was added
and incubated for 10 minutes, then washed with
PBS for 2 x 2 minutes.
One (1) mL DAB chromogen betazoid diluted
with 100 mL betazoid susbtrate DAB buffer
immediately before used. Sample incubated in
DAB chromogen substrate above 30 mL per
sample for 10 minutes, then washed with tap
water. Mayer hematoxylin (counterstain) was
added to the sample then incubated for 1-3
minutes, washed under tap water and dried.
Furthermore, dipped in alcohol, dried and
cleaned and then covered with entellan and
cover glass. Ready to be examined under a
microscope at a magnification of 40x, 100x, 400x
and 1000x. Cell preparations showed a brown
color at the cytoplasm or contained brown
granules around the cell means Dengue - 2
antigen positive, whereas cells showed blue or
pale and there are no brown granules around
the cell as a negative control. Positive rate result
from Immunocytochemistry examination was
analyzed by ANOVA with 95 % Confidence
Interval (CI).
RESULT AND DISCUSSION
Cytotoxic test of curcumin
Test is intended to determine the cytotoxic
of curcumin. Test performed by the MTT method.
3 - (4,5-dimetiiazol-2-i1) -2,5 difeniltetrazolium
bromide (MTT) is absorbed into the cells and
reduced the mitochondria-dependent reaction
into formazan crystals that can be measured
using ELISA reader spectophotometric at 595
nm. Dimethyl-sulfoxide (DMSO) which is used
as a solvent of curcumin known to have no effect
on vero cell death. Research using DMSO as a
solvent in the cytotoxicity test against HSC-4 did
not affect the cell growth12,13.
Percentage living of vero cells after adminis-
tration by curcumin can be viewed as the
following graph.
Figure 2. Percentage living vero cells after adminis-
tration of curcumin
Figure 2. Showed the result of curcumin
cytotoxic test against vero cells. The decrease of
the concentration of curcumin was positively
correlated with the percentage of living cells.
The results showed cytotoxic concentrations of
curcumin that safe to vero cells was 6.26 ppm is
due to the results of the calculation of percent
concentration of living cells has reached 100%.
In vero cell cultures treated with curcumin
at rise concentrations was appears the vero cell
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morphological changes. Vero cell death
mechanisms at the molecular level as a result
of administration of curcumin can’t be known
by the cytotoxicity assay. Reactivity curcumin was
capable of interacting with cellular components
such as DNA, membrane lipids and other cellular
proteins that will affect biological processes in
the cell such as cell cycle, metabolism and
apoptosis14. Curcumin is known have the ability
to stimulate apoptosis in various cancer cell
culture15. Viewed lipophilic nature, curcumin
easily related to the cell and modulate nuclear
transcription factors or protein kinases, leading
to caspase-activated DNAse enters the nucleus
and degrade DNA12. Depth studies related to the
apoptotic process can be performed to
determine this.
Antiviral Test with SBPC immunocyto-
chemistry
Antiviral test of curcumin is known through
immunocytochemistry test. This immunocyto-
Figure 3. Microscopic photograph at a 40 x 10 magnification of vero cells infected by Dengue-2 virus were
incubated 1 and 3 days and treated with curcumin examination by SBPC immunocyto-chemistry. One
(1)dayspositivecontrol (A),one(1)daysnegativecontrol (B),curcumintreatmentwith1days incubation
of Dengue-2 infection (C), 3 days positive control (D), 3 days negative control (E), curcumin treatment
three 3 days incubation of Dengue-2 infection (F).
chemistry using biotin labeled secondary
antibody that can recognize the primary
antibodies and using the enzyme labeled
streptavidin conjugated with horseradish
peroxidase and chromogen substrate mixture
to detect antigens on the cell or tissue with a
high sensitivity, so that the low level of antigen
can be detected. Straptavidin Biotin Peroxidase
Complex (SBPC) base reaction was a very strong
bond between streptavidin and biotin.16
Test results showed SBPC immunocyto-
chemistry with DSSE10 primary antibodies able
to detect Dengue-2 virus infection at 1 day
incubation that indicated by the light brown
color wass formed and the 3 day incubation
formed brown look older. Positive control,
negative control were used to control the work.
The specificity of immunocyto-chemistry should
be validated with the negative control and
positive control showed the antibody binding.17
The immunocytochemistry assay results can be
seen in figure 3 below.
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Figure 3. showed the effect of curcumin on
vero cells infected Dengue - 2 incubation 1 and
3 days. At vero cell were incubated 1 day
infection (both positive control (A) or treated
with curcumin (C)) are visible positive reaction.
A positive reaction seen by the presence of light
brown colour on vero cell cytoplasm. Negative
control 1 (one) day (B) and negative controls 3
(three) days (E) appears blue colour on
cytoplasm. Sample which incubated 3 days of
infection looks more positive reaction when
compared with 1 day incubation infection. On
microscopic observation brown color intensity
in vero cells were incubated 3 days of infection
seen dark brown colour on cytoplasm.
Immunocytochemistry results are quali-
tative methods, but very sensitive, specific and
valid for Dengue diagnostic18. This method
allows researchers to determine the sub -cellular
compartement containing antigen. Widiastuti
research (2011)19showed that the SBPC immuno-
cytochemistry with DSSE10 antibodies have a
high sensitivity and specificity diagnostic (100 %
and 91 %).
The calculation of the positive rate.
The calculation of the positive rate results
from SBPC immunocytochemistry using DSSE10
monoclonal antibody on vero cell looks like in
table 1 below .
Table 1. Positive value rate vero cells infected by
Dengue-2 incubation 1 day and 3 days
Table 1 shows the value of a positive rate of
vero cells infected by Dengue - 2 incubation 1
and 3 days to be curcumin treatment. When
compared to the positive controls seem a
significant difference, so it can be interpreted
that curcumin can decrease the positive rate
values due to Dengue - 2 infection.
Curcumin is known to suppress viral
replication with proteasome inhibitors. The
endocytosis process for virus penetration was
regulated by the Ubiquitin Proteasome System
(UPS) . Ubiquitin Proteasome System has a role
in replication, maturation and assembly of
viruses. Provision of proteasome inhibitors such
as MG123 is known to inhibit the production of
virus20. Study of Dutta et al., (2009 )7 state that
curcumin can decreased the viral particles of
Japanese encephalitis through ubiquitin protea-
some mechanism. Effect of curcumin adminis-
tration against Japanese encephalitis was expect-
ed gives similar results when given in Dengue
virus, because both types of virus are in the same
type of flavivirus, but further research is needed
to know about it.
CONCLUSION
The results showed that secure concentrat-
ions from cytotoxic of curcumin against vero cells
is 6.25 ppm. The calculation of positive rate from
immunocytochemistry in vero cells infected by
Dengue - 2 incubation 1 and 3 days were the
result is significantly different than the control,
it means curcumin can lower positive rate due
to Dengue-2 infection.
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